United Therapeutics UTHR
NASDAQ UTHR
$546.02 +64.55 (+13.41%)
As of: Sep 30, 2026 · 11:59 AM EDT

United Therapeutics (UTHR) Convertible Debt (2011 - 2013)

Updated

United Therapeutics' Convertible Debt came in at $207.38 million for Q1 2013, up 5.4% from $196.73 million a year earlier and up 1.3% from the prior quarter.

Analysis

United Therapeutics (UTHR) Convertible Debt (2011 - 2013) Analysis & Trends

At the end of FY2012, United Therapeutics' Convertible Debt was $204.67 million, up 5.4% from FY2011.

  • Going back by year, Convertible Debt was $194.18 million in FY2011.
  • Business Quant data shows UTHR's Convertible Debt at $204.67 million (Q4 2012), $201.97 million (Q3 2012) and $199.34 million (Q2 2012) in the three quarters before Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 United Therapeutics 20.72 Bn 10.22 Bn 683.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 207.38 Mn
Dec 31, 2012 204.67 Mn
Sep 30, 2012 201.97 Mn
Jun 30, 2012 199.34 Mn
Mar 31, 2012 196.73 Mn
Dec 31, 2011 194.18 Mn
API Access

United Therapeutics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=UTHR&period=max&api_key=YOUR_API_KEY